Difference between revisions of "FNSGp"
From Bioblast
Line 10: | Line 10: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT reference protocol]], [[Gnaiger | |info=[[MiPNet21.06 SUIT reference protocol]], [[Gnaiger 2020 BEC MitoPathways]] | ||
}} | }} | ||
::: ''More details'' Β | ::: ''More details'' Β | ||
Line 43: | Line 40: | ||
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | [[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]] | ||
---- | ---- | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} |
Revision as of 19:57, 1 January 2021
Description
MitoPathway control state: FNSGp
- Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glycerophosphate.
SUIT protocol: SUIT-002
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: FNSGp
Reference: MiPNet21.06 SUIT reference protocol, Gnaiger 2020 BEC MitoPathways
FNSGpL
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols:
FNSGpP
FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
FNSGpE
FNSGp pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
MitoPedia concepts:
SUIT state